Agreement and Plan of Merger Between MyMD Pharmaceuticals, Inc., a New Jersey Corporation and MyMD Pharmaceuticals, Inc., a Delaware CorporationMerger Agreement • March 7th, 2024 • MyMD Pharmaceuticals, Inc. • In vitro & in vivo diagnostic substances • Delaware
Contract Type FiledMarch 7th, 2024 Company Industry JurisdictionThis Agreement and Plan of Merger (the “Agreement”), dated as of March 4, 2024, is made by and between MyMD Pharmaceuticals, Inc., a New Jersey corporation (the “Company”), and MyMD Pharmaceuticals, Inc. (d/b/a MyMD Sub, Inc.), a Delaware corporation and a wholly owned subsidiary of the Company (“Newco”).